ABSTRACT. The correlation between the -104C/T polymorphism in the peptidyl arginine deiminase 4 (PADI4) gene and rheumatoid arthritis (RA) risk has been analyzed in several studies. However, the results are inconclusive and remain to be confirmed in several ethnic groups. The effect of the PADI4-104C/T polymorphism on RA risk in the Chinese population was evaluated in a meta-analysis. Studies with dates of publication up to July 2015 conforming to the inclusion criteria were retrieved from PubMed and Chinese databases. The associations were assessed with pooled odds ratios (ORs) and 95% confidence intervals (CIs). Ten studies, including 2119 RA cases and 1962 controls, that conformed to the study criteria were included in this analysis. The overall analysis indicated a significant association between the PADI4- 30-2.37) . Analysis of data stratified by the geographic area and source of controls revealed that the PADI4-104C/T polymorphism was significantly associated with RA risk in a North Chinese population. In conclusion, the results of this meta-analysis indicated that the PADI4-104C/T variants could influence the risk of RA in the Chinese population; further studies in other ethnic groups are required to draw definite conclusions.
INTRODUCTION
Arthritis and other rheumatic conditions are prevalent worldwide. However, there are several regional and racial differences in the prevalence of different types of rheumatic diseases (Johnsen et al., 1992; Sangha, 2000; Dai et al., 2003) . Rheumatoid arthritis (RA) affects approximately 1% of the global population, with genetic factors accounting for ~60% of the disease risk (Turesson and Matteson, 2006) . Many candidate genes have been identified as potential RA susceptibility loci. One such gene is the peptidyl arginine deiminase 4 (PADI4) gene, a member of the PADI gene family that codes for enzymes involved in the posttranslational conversion of arginine to citrulline. Several polymorphisms have been identified in the promoter region of PADI4, which is located on chromosome 1p36. Of these, the -104C/T (or rs1748033) single nucleotide polymorphism (SNP) has been extensively studied. In 2003, Suzuki et al. (2003) identified an association between the PADI4 -104C/T polymorphism and rheumatoid arthritis in a Japanese population. Consequently, several studies have attempted to clarify this relationship; however, there has been no definite consensus to date. Differences in the results of these studies may be attributed to the ethnic and clinical heterogeneity of the patients studied or the relatively small number of patients included in the studies.
Meta-analyses, which combine the results of several studies, have greater statistical power. Several meta-analyses have been previously conducted on RA in the Asian and Caucasian populations, with conflicting results (Lee et al., 2007; Hou et al., 2013; Lee and Bae, 2015; Yang et al., 2015) . This meta-analysis was performed to filter out the influence of different genetic backgrounds on the relationship between the PADI4-104C/T polymorphism and risk of RA in a Chinese population. The data was also subjected to a subgroup analysis by stratifying the data according to the geographic location and source of control population, to explore the possible effects of gene-environment interactions on RA risk.
MATERIAL AND METHODS

Search strategy and selection criteria
Studies reporting on the relationship between the PADI4-104C/T polymorphism and RA up to July 25, 2015 were retrieved from PubMed and Chinese databases using the search keywords "PADI4", "peptidyl arginine deiminase 4", "-104C/T", "rheumatoid arthritis", "Chinese", "China", and "Taiwan". The search was performed with no language restrictions, and focused on human studies only. The references cited in the retrieved articles were also searched.
The inclusion criteria for study selection were as follows: 1) case-control or cohort studies describing the association between the PADI4-104C/T polymorphism and RA, 2) patients diagnosed with RA based on the classification criteria proposed by the American College of Rheumatology for RA, 1987, 3) clear description of the PADI4-104C/T polymorphism in RA patients and controls, and 4) Chinese subjects only. Duplicate publications, studies with incomplete data, those without controls, and meta-analyses, letters, meeting abstracts, reviews, and editorial articles were excluded from this analysis.
Data extraction
Data was retrieved independently by two authors from all included publications. Disagreements were resolved by discussion. The titles and abstracts of all potentially relevant articles were screened to determine their relevance. Full articles were scrutinized in case of ambiguity in the title and abstract. The following data were extracted from the identified studies: name of the first author, publication year, source of controls, geographic area, sample size, and number of subjects expressing the PADI4-104C/T genotype.
Statistical analysis
The data was analyzed using the STATA v.10 software package (STATA, College Station, TX, USA). The genotype distribution in the controls was tested for conformance with the Hardy-Weinberg equilibrium (HWE) using the chi-square test, and deviations were indicated by P values < 0.05. The association between the PADI4-104C/T polymorphism and RA risk was estimated by the odds ratios (ORs) with their 95% confidence intervals (CIs). Heterogeneity was tested by Q-statistic with P values < 0.10. In case of heterogeneity, the random-effect model was used to pool the ORs (with their corresponding 95%CIs); the fixedeffect model was used in other cases. The significance of the pooled OR was determined by a Z-test. A sensitivity analysis was conducted to illustrate the accuracy and stability of the analytical results. Sensitivity analyses were conducted by deleting individual studies included in the meta-analysis. Publication bias was assessed by Begg's funnel plot and the Egger linear regression test. The data was stratified according to the geographic area and source of controls and subsequently analyzed. Two-sided P values less than 0.05 were considered to be statistically significant.
RESULTS
Description of included studies
The literature search strategy and the study selection criteria are depicted in Figure 1 . A total of 57 articles that analyzed the association between PADI4 polymorphisms and risk of RA were identified after the removal of duplicate studies obtained from different databases. A thorough screening of the titles and abstracts resulted in the exclusion of 44 reviews or meeting abstracts, studies conducted in a non-Chinese population or those irrelevant to this study. Of the 13 potentially relevant articles (Cui et al., 2007; Lu, 2007; Fan et al., 2008 Fan et al., , 2009 Feng et al., 2010; Shi, 2010; Shi et al., 2010; Wei, 2010; Chen et al., 2011; Xu et al., 2011; Liu et al., 2012; Du et al., 2014) , three duplicate studies were excluded (Fan et al., 2009; Shi, 2010; Wei, 2010) . Finally, 10 case-control studies that met the inclusion criteria (Cui et al., 2007; Lu, 2007; Fan et al., 2008; Feng et al., 2010; Shi et al., 2010; Chen et al., 2011; Xu et al., 2011; Liu et al., 2012; Du et al., 2014) were included in this study. The included studies were published between 2007 and 2014. In total, 2119 RA cases and 1962 controls were included in this meta-analysis. The source of controls was populationbased in nine studies. The characteristics of included studies are summarized in Table 1 . 
Meta-analysis
The primary results of the meta-analysis are summarized in Table 2 . Overall, all variants of the PADI4-104C/T SNP were associated with a significantly elevated risk of RA (TT vs CC: OR = 1.49, 95%CI = 1.24-1.80; TT vs CC+CT: OR = 1.28, 95%CI = 1.08-1.51; TT+CT vs CC: OR = 1.75, 95%CI = 1.30-2.37). The pooled OR of the allele distribution at this SNP site (T vs C) was 1.45 (95%CI = 1.18-1.78) (Figure 2) . ORr: odds ratio for random-effect model; ORf: odds ratio for fixed-effect model; CI, confidence interval; P h : P value for heterogeneity test. The North China region included the Hebei, Anhui, Henan, Qinghai, Inner Mongolia, and Beijing provinces. Only Shanghai was included from the South China region. The results of the subgroup analysis based on source of controls revealed a significant correlation between the PADI4-104C/T polymorphism and RA risk in the studies with population-based controls (T vs C: OR = 1.39, 95%CI = 1.14-1.70; TT vs CC: OR = 1.44, 95%CI = 1.20-1.74; TT vs CC+CT: OR = 1.24, 95%CI = 1.04-1.47; TT+CT vs CC: OR = 1.75, 95%CI = 1.30-2.37) ( Table 2 ). Analysis of the data stratified according to the geographic area revealed that these polymorphisms induced a significantly higher risk of RA in the Northern Chinese population (T vs C: OR = 1.28, 95%CI = 1.16-1.41; TT vs CC: OR = 1.54, 95%CI = 1.26-1.89; TT vs CC+CT: OR = 1.32, 95%CI = 1.09-1.59; TT+CT vs CC: OR = 1.40, 95%CI = 1.21-1.61) ( Table 2 ).
Sensitivity and bias diagnosis
The differences between studies were compared and the sensitivity of the metaanalysis was evaluated by analyzing the overall data after deleting individual studies to reflect the influence of the individual data-set on the pooled OR. The pooled OR was not altered significantly in the overall analysis (Figure 3) . Therefore, the conclusions of this meta-analysis are relatively stable and credible for the overall analysis. The publication bias in the included studies was assessed by the Begg's funnel plot and the Egger test. The shape of the funnel plots did not reveal obvious asymmetry (Figure 4) . Similarly, the Egger test indicated no publication bias in the reviewed studies (t = 0.52, P = 0.619). 
DISCUSSION
Despite the well-known multifactorial nature of RA, genetic factors are considered to be the strongest determinants of this disease, encouraging researchers to search for the responsible genes (Turesson and Matteson, 2006; Yang et al., 2015) . The first positive association between PADI4-104C/T and RA was reported in a Japanese population (Suzuki et al., 2003) ; several studies have attempted to replicate this association since then. However, the results of individual studies remained inconclusive. A previous meta-analysis reported a significant association between the PADI4-104C/T polymorphism and RA risk in Asian and European populations (Lee and Bae, 2015) , while other meta-analyses reported a significant association between this polymorphism and RA in Asian individuals only (Lee et al., 2007; Hou et al., 2013) . These conflicting results could be attributed to various regional and racial differences. Therefore, this meta-analysis was conducted to provide a precise estimate of the association between the PADI4-104C/T SNP and RA susceptibility in the Chinese population, in order to lessen the impact of regional and racial differences. Ten case-control studies, comprising 2119 RA cases and 1962 controls, were included in this meta-analysis. The results of this study showed a significant overall association between the PADI4-104C/T polymorphism and RA. To our knowledge, this is the first meta-analysis evaluating the association between the PADI4-104C/T variants and RA in a Chinese population (with a large sample size).
In the subgroup analyses, wherein the cases and controls were stratified according to the geographic area and source of controls, we identified a significant association between this polymorphism and RA risk in the North Chinese population, and not in the South Chinese population. This showed that Northern Chinese subjects expressing the T variant of PADI4-104C/T were more susceptible to RA compared to Southern Chinese subjects. These suggest the possible effect of the geographic differences and environment on the genetic background of the population. However, we were unable to stratify the data based on the differences in ethnicity and other environmental factors because of insufficient data. Therefore, studies on RA-related genes should be based on the region and nationality; additionally, a larger number of associated genes must be simultaneously tested in a greater number of people (larger sample size) in the future.
This study is subject to several limitations. First, this meta-analysis only included data from Chinese patients with RA; therefore, our results are only applicable to this ethnic group. Secondly, as this meta-analysis was primarily based on unadjusted effect estimates and CIs, potential confounding factors were not controlled. Thirdly, differences in the genotyping methods and disease statuses might affect the interpretation of the data of included studies. However, our meta-analysis also has several strong points. Firstly, the inclusion and exclusion criteria were meticulously adhered to, in order to reduce possible selection bias. In addition, the conformance of the genotype distribution in the control groups to the HWE suggested the lack of significant differences in the genetic backgrounds among the participants. Thirdly, the sensitivity analysis confirmed the reliability and stability of this meta-analysis, and the Egger test indicated no publication bias among the included studies. Finally, the effect of different genetic backgrounds was minimized by including only studies conducted in the Chinese population. Therefore, the findings of this meta-analysis provide strong evidence regarding the association between the PADI4-104C/T polymorphism and RA in the Chinese population.
In conclusion, this meta-analysis demonstrated that the PADI4-104C/T polymorphism might be a significant risk factor for RA in the Chinese population; in particular, this polymorphism appeared to play a larger role in RA susceptibility in the northern Chinese
